Drug
LY03017 clinical trials
Also written LY03017.
Keep track of what changes. Save the LY03017 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- LY03017
- 3
Studies by the year they started
3 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses LY03017 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017Not yet recruitingPhase 1Luye Pharma Group Ltd.NCT06980207Written as LY03017
- Effect of Food and Age on the Pharmacokinetics of LY03017Not yet recruitingPhase 1Luye Pharma Group Ltd.NCT06793995Written as LY03017
- A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017Status unknownPhase 1Luye Pharma Group Ltd.NCT06388551Written as LY03017